Skip to main content
. 2017 Nov 17;11(1):24–30. doi: 10.1016/j.tranon.2017.10.006

Figure 5.

Figure 5

Renal and hepatic toxicity in mice treated with 64Cu-ATSM. Renal and hepatic toxicity was examined among each treatment group similar to that in the in vivo treatment analysis with 64Cu-ATSM. Data were measured at day 49 after first 64Cu-ATSM and saline injection (control) (n = 5/group). (A) Levels of urea nitrogen (BUN) and creatinine (CRE) for kidney function. (B) Levels of glutamate pyruvate transaminase (GPT) and alkaline phosphatase (ALP) for liver function.